Table 1. Demographic data and clinical outcomes of participants.
| Characteristics | LUS (n = 140) | LUS + CT (n = 96) | All (n = 236) | p-value * |
|---|---|---|---|---|
| Age | 5.53 ± 3.62 | 4.88 ± 4.13 | 5.26 ± 3.84 | 0.202 |
| Male gender | 75 (53.6) | 44 (45.8) | 119 (50.4) | 0.289 |
| Pathogens # (%) | 22/42/33/0/2 | 14/72/6/2/6 | 19/54/22/1/4 | < 0.001 |
| Initial presentations | ||||
| Leukocyte, × 109/L | 14.3 ± 9.5 | 16.7 ± 8.8 | 15.3 ± 9.3 | 0.048 |
| CRP, mg/dL | 168 ± 111 | 227 ± 114 | 192 ± 116 | < 0.001 |
| Coagulopathy | 12/140 (8.6) | 28/96 (29) | 40/236 (17) | < 0.001 |
| Shock | 4/140 (2.6) | 6/96 (6.3) | 10/236 (4.2) | 0.324 |
| Clinical outcome | ||||
| Pneumatocele | 3/140 (2.1) | 31/96 (32.3) | 34/236 (14.4) | <0.001 |
| Bronchopleural fistula | 1/140 (0.7) | 13/96 (13.5) | 14/236 (5.9) | <0.001 |
| Tube insertion | 29/140 (20.7) | 18/96 (18.8) | 47/236 (19.9) | 0.743 |
| Fibrolytics $ | 12/140 (8.6) | 14/96 (14.6) | 26/236 (11) | 0.203 |
| VATS | 1/140 (0.7) | 42/96 (43.8) | 43/236 (18.2) | < 0.001 |
| Lung resection | 1/140 (0.7) | 15/96 (15.6) | 16/236 (7.8) | < 0.001 |
| Hospital day | 8.47 ± 4.01 | 15.52 ± 6.91 | 11.32 ± 6.41 | < 0.001 |
Data are presented as median ± SD, n/N (%), and No. (%), unless otherwise indicated.
CRP = C-reactive protein; VATS = video-assisted thoracoscopic surgery
# Unknown/Pneumococcus pneumoniae/Mycoplasma pneumoniae/Staphylococcus aureus/others
* Comparing with (LUS) and (LUS + CT) groups
$ Treatment with intrapleural fibrolytics